Baheti Akshay D, Yeh Matthew M, O'Malley Ryan, Lalwani Neeraj
Department of Radiology, University of Washington, Seattle, USA.
Department of Pathology, University of Washington, Seattle, USA.
J Clin Imaging Sci. 2015 Aug 31;5:47. doi: 10.4103/2156-7514.163991. eCollection 2015.
Hepatocellular adenoma is a heterogeneous group of benign neoplasms arising from hepatocellular cells and can be subclassified into four major groups based on genotypic and phenotypic characteristics. These four subtypes are hepatocyte nuclear factor (HNF) 1α-inactivated, β-catenin-activated, inflammatory, and unclassified adenomas. Immunohistochemistry studies have demonstrated that since β-catenin-activated adenomas have a higher risk of malignant transformation, the identification of the subtype of adenoma remains crucial in patient management. However, malignant transformation of hepatic adenoma without β-catenin overexpression can be seen in 30-65% cases. We report a case of malignant transformation of hepatic adenoma without overexpression of β-catenin in a 31-year-old man with a known glycogen storage disease (GSD) Type-1a, which was diagnosed on surveillance magnetic resonance imaging (MRI). The MRI showed a mild interval increase in one lesion with relative stability of the other adenomas. The lesion was presumed to be suspicious for a hepatocellular carcinoma (HCC) and was confirmed on pathology.
肝细胞腺瘤是一组起源于肝细胞的异质性良性肿瘤,可根据基因型和表型特征分为四大类。这四种亚型分别是肝细胞核因子(HNF)1α失活型、β-连环蛋白激活型、炎症型和未分类腺瘤。免疫组织化学研究表明,由于β-连环蛋白激活型腺瘤具有较高的恶性转化风险,腺瘤亚型的鉴定在患者管理中仍然至关重要。然而,30%-65%的病例中可见无β-连环蛋白过表达的肝腺瘤发生恶性转化。我们报告一例31岁已知1a型糖原贮积病(GSD)男性患者,其肝腺瘤在无β-连环蛋白过表达的情况下发生恶性转化,通过监测磁共振成像(MRI)诊断。MRI显示一个病灶轻度渐进性增大,其他腺瘤相对稳定。该病灶被怀疑为肝细胞癌(HCC),病理检查得以证实。